AVROBIO, INC.

• CAMBRIDGE, MA How do I update this listing?

Avrobio is based out of Cambridge. Avrobio, Inc. operates as a bio-technology company. The Company develops step-change cell and gene therapies for the treatment of cancer and rare disease. Avrobio serves clients in the United States and Canada. The firm last filed a Form D notice of exempt offering of securities on 2018-02-02. The notice included securities offered of Equity

Contact Info

avrobio, inc.
ONE KENDALL SQUARE
CAMBRIDGE MA 02139
Business Phone: 7819626030

SEC SIC CODE:
2836-BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)

Recent SEC Filings

Active Schedule 13D and 13G events

Sign in to see

Insider Transactions in the past year

Form D Filings

Form D is a form to be used to file a notice of an exempt offering of securities with the Securities and Exchange Commission. Form D contains basic information about the offering and the company.

Form D Filings
Filing Date	Form Type	Industry Group	Securities Offered	Total Offering Amount	Total Amount Sold	Total Remaining
2018-02-02	D	BIOTECHNOLOGY	Equity	60,999,978	60,499,978	500,000
2016-08-03	D	BIOTECHNOLOGY	Equity	25,000,000	7,500,000	17,500,000

Other Issuers in Filings
Name	Address
No Other Issuers

Related Parties included in filings
Name	Address	Relationship
BRUCE BOOTH	subscription required	DIRECTOR
CHRISTOPHER MASON	subscription required	EXECUTIVE OFFICER
CHRISTOPHER PAIGE	subscription required	DIRECTOR
DEANNA PETERSEN	subscription required	EXECUTIVE OFFICER
GEOFFREY MACKAY	subscription required	EXECUTIVE OFFICER DIRECTOR
IAN CLARK	subscription required	DIRECTOR
JOSHUA RESNICK	subscription required	DIRECTOR
KATINA DORTON	subscription required	EXECUTIVE OFFICER
KIM WARREN	subscription required	EXECUTIVE OFFICER
SCOTT REQUADT	subscription required	DIRECTOR